Equivalence test data for control drug to be submitted within two months after selection

The Korea Food and Drug Administration (KFDA) announced that a drug manufacturer should submit to the necessary equivalence test data on control drug within two months after its selection and unless otherwise submitted, its notice will be cancelled, according to its envisioned draft.

The KFDA said that although a drug manufacturer is required to submit the dissolution test data of control dr...